Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 247 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-WARFARIN | 2.5MG | TABLET | Resolved | 2020-01-08 | 2020-06-08 | 102671 |
APO-CILAZAPRIL | 2.5MG | TABLET | Resolved | 2020-03-04 | 2020-05-15 | 107693 |
APO-OLANZAPINE | 2.5MG | TABLET | Resolved | 2020-06-04 | 2020-07-28 | 116547 |
APO-CILAZAPRIL | 2.5MG | TABLET | Resolved | 2020-06-10 | 2020-09-14 | 117377 |
APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-08-06 | 2020-09-04 | 121903 |
APO-OLANZAPINE | 2.5MG | TABLET | Resolved | 2020-09-09 | 2020-12-17 | 123957 |
APO GLYBURIDE TAB 2.5MG | 2.5MG | TABLET | Resolved | 2020-09-17 | 2020-10-05 | 124350 |
APO-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2020-11-04 | 2020-12-29 | 127754 |
APO-ENALAPRIL | 2.5MG | TABLET | Resolved | 2020-11-26 | 2021-03-09 | 128942 |
APO-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-01-08 | 2021-02-09 | 131166 |
APO-FROVATRIPTAN | 2.5MG | TABLET | Resolved | 2021-07-16 | 2021-09-01 | 142680 |
APO-MEDROXY TABLETS | 2.5MG | TABLET | Resolved | 2021-10-15 | 2022-01-31 | 147299 |
APO-MIDODRINE | 2.5MG | TABLET | Resolved | 2022-01-07 | 2022-04-22 | 152313 |
APO-SAXAGLIPTIN | 2.5MG | TABLET | Resolved | 2022-01-14 | 2022-07-19 | 152773 |
APO-TADALAFIL | 2.5MG | TABLET | Resolved | 2022-03-11 | 2022-04-01 | 156555 |
APO-FROVATRIPTAN | 2.5MG | TABLET | Resolved | 2022-06-30 | 2022-09-02 | 163722 |
APO-LETROZOLE | 2.5MG | TABLET | Resolved | 2022-09-01 | 2022-09-16 | 168415 |
APO-OLANZAPINE | 2.5MG | TABLET | Resolved | 2022-10-28 | 2022-12-09 | 172901 |
APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-02-09 | 2023-03-02 | 184086 |
APO-LETROZOLE | 2.5MG | TABLET | Resolved | 2023-03-09 | 2023-03-16 | 186589 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-CETIRIZINE | Discontinued | 2018-05-31 | 2018-05-31 | 50998 | ||
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
APO-CYCLOSPORINE ORAL SOLUTION | Discontinued | 2018-09-07 | 2018-09-15 | 60408 | ||
APO-FAMOTIDINE TAB 20MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60477 | ||
APO-FAMOTIDINE TAB 40MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60480 | ||
APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 | ||
APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 |